A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

Influenza significantly impacted adults aged 50 to 64 years and younger adults with chronic conditions, but risk can be reduced with RIV.

Exploring the virus infection mechanisms is significant for defending against virus infection and providing a basis for studying endocytosis mechanisms. Single-particle tracking technique is a ...

In this context, we recently identified a potential new type of physiological mechanism leading to enhanced activation of antiviral immunity in response to virus infection: an influenza A virus ...

Influenza A virus (IAV) infection triggers derepression of host transposable elements (TEs), which have the potential to form double-stranded (ds)RNAs and could enhance innate antiviral immunity.

Since the beginning of the COVID-19 pandemic, public health experts have worried about people getting infected with the influenza virus and SARS-CoV-2 at the same time, a disease sometimes called ...

Mortality and economic contraction during the 1918-1920 Great Influenza Pandemic provide plausible upper bounds for outcomes under the coronavirus (COVID-19). Data for 48 countries imply flu-related ...

Nirsevimab offers consistent and sustained protection against hospitalisation due to RSV-associated lower respiratory tract infection for at least 6 months. This finding provides global health systems ...

New CDC research suggests the H5N1 avian influenza virus that infected a Michigan dairy farmworker can be transmitted through the air. The revelation, the study's authors wrote, suggests "an ...

A new study shows how person-to-person variation in antibody immunity plays a key role in shaping which influenza (flu) strains dominate in a population.